ParenteralDosed ingredient Cosmetic cross-reference

Arginine Hydrochloride

CAS 1119-34-2

Arginine Hydrochloride (CAS 1119-34-2) is a Phase 4 pharmaceutical compound with 1 bioactivity target and 6 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
1
SOURCE DrugCentral
Adverse signals
6
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Arginine Hydrochloride
CAS Number
1119-34-2
UNII
F7LTH1E20Y
InChIKey
KWTQSFXGGICVPE-WCCKRBBISA-N
ChEMBL ID
CHEMBL1200381
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
ARGININE HCL
dosed ingredientparenteral
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1200381 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- AC50 30000 nM 30 -
SOURCE NLM RxNorm 6 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
Arginine Hydrochloride 89918 SU MTHSPL
ARGININE HCL 89918 SU MTHSPL
ARGININE HYDROCHLORIDE 89918 SU MTHSPL
Arginine hydrochloride 89918 SU MTHSPL
arginine hydrochloride 89918 SU MTHSPL
arginine hydrochloride 89918 PIN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Arginine Hydrochloride used for in pharmaceutical contexts?

Arginine Hydrochloride (CAS 1119-34-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Arginine Hydrochloride?

Arginine Hydrochloride has 6 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Heart rate increased, Initial insomnia, Malaise, Muscle spasms, Pain in extremity. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Arginine Hydrochloride also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Arginine HCl with EU status "permitted".

What clinical phase is Arginine Hydrochloride in?

Arginine Hydrochloride is rendered with ChEMBL max phase 4 (approved).